Just Other Articles

The Securities and Exchange Commission (SEC) is the most well-known and feared governing body in the financial world. Its very name can be intimidating to a sma

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ll company hoping to go public, but it doesn’t have to be.

The SEC was established by Congress to regulate securities markets with the intent of protecting inve

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

stors. For this reason, it requires registration for the issuance of almost any kind of securities, including mail or internet-based issues.

In an initial publ

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ic offering, the process of filing necessary paperwork with the SEC can be time-consuming and complicated. First, a registration for must be filed and declared

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

effective. Despite the fact that the registration becomes public knowledge immediately, the company may not attempt to sell shares until the registration is dec

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

lared effective. Registration documents include a prospectus to be given to all investors, as well as a section that is made available on the SEC website but wh

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ich does not have to be provided to investors. A company’s underwriter will prepare and file these documents with the help of accountants and lawyers.

For a co

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

mpany that has gone public through an IPO, SEC requirements don’t end with the issuance of shares. Continued disclosures must be made concerning a variety of to

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

pics, including details of operations, key employees and shareholders, major stock transactions, and general health of the company. Because these disclosures ar

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

e so numerous and frequent, there is a substantial cost involved that should not be overlooked when making the decision to go public.

Despite the expense of SEC

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

compliance, the cost of issuing stock would be higher without the SEC. Because of SEC regulations, a large pool of information is available to potential investo

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

rs. Further, many otherwise unethical businesses are given good motivation to avoid misrepresentation on company financial documents. This makes investing safe

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

r for everyone, and allows investors to trade with less prejudice at higher prices.

For smaller businesses, the process of issuing shares is less complicated.

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

Shortened forms and procedures allow businesses seeking smaller amounts of capital to publicly sell shares without the use of an underwriter. These rules also a

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

llow slightly reduced reporting requirements, as compared to companies going public through an initial public offering. The overall effect is a public issuance

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

that costs significantly less than the traditional process for going public.

More recent SEC rules also allow for the public trading of direct public offerings

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

issued by those small companies. With the appropriate filings in place, small companies can apply to have their shares traded on over-the-counter bulletin board

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

exchanges, giving added liquidity to their offerings. In this manner, the SEC has helped to encourage small business and innovation by democratizing the availa

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

bility of capital.

Despite the often negative opinions about the SEC and its requirements, it is an organization that acts in the best interest of investors and

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

for the overall good of the market. Proper attention and diligence can ensure that an offering goes smoothly in spite of the inconvenience of necessary filings

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/3541/justotherarticles-Going-Public-via-Initial-or-Direct-Public-Offering-Role-of-the-Securities-and-Exchange-Commission.html">Going Public via Initial or Direct Public Offering: Role of the Securities and Exchange Commission</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/3541/justotherarticles-Going-Public-via-Initial-or-Direct-Public-Offering-Role-of-the-Securities-and-Exchange-Commission.html]Going Public via Initial or Direct Public Offering: Role of the Securities and Exchange Commission[/url]

Should you pursue your MBA before you start your business? More importantly, will your lack of business education prevent you from being a successful business owner? Just like the question of nature vs. nurture, there is more to business success than a formal education.

5 Ways a Document Management Service Can Improve Your Business Documents can be the bane of any businessman's existence. Documents are a fact of life in the business world. From advertisements to l...

Tags

Links

Just Other Articles - Going Public via Initial or Direct Public Offering: Role of the Securities and Exchange Commission

Related Articles: